How can ITO/BPO help firms compete internationally?
It is difficult to imagine that by outsourcing something like
finance, procurement, information technology, or human resources
that firms can increase their revenue but it's true. It may be
indirect but by improving the businesses focus, by stripping away
non-core activities biotech and technology firms can improves their
ability to focus on revenue generating activities. This matters all
the more if you are competing on the international stage. For
readers of Global Watch Magazine, this subject is timely
and can achieve real benefits for your organisations.
The term outsourcing gained common acceptance in the 1980s and is
still used today to describe a relationship with an outside service
provider for work traditionally done in-house. The important
distinction between an outsourcing deal and any other business
relationship is that in outsourcing, control of the process is
determined not by the client, but by the supplier. The client
dictates what it wants to gain from the relationship, but it is
left to the supplier to set the strategy to accomplish the
implementation and delivery.
This method of outsourcing was mainly seen as giving most benefit
in the technology departments of organisations. Latterly, with the
technology outsourcing (ITO) market becoming more mature certainly
in the UK, the US, Germany and Scandinavia, Business process
outsourcing, or BPO, has come to the notice of Boards.
BPO is a more comprehensive, or business process oriented,
approach. Instead of outsourcing along traditional functional
lines, the scope of the services covered by the deal cuts across
the organisation in a more holistic way. Generally, BPO contracts
are seen as being more inclusive, covering a great deal of process
redesign work, redeployment and retraining of the people
transitioned to the supplier, and almost always includes the
information technology that enables and supports the business
process. The goal is to provide an even greater opportunity for
generating innovation, speed to market and shareholder value
through this more integrated approach.
BPO deals have seen a huge increase in both their size and
frequency over the past year. In the HR outsourcing market, 2001
saw an increase of 65 per cent year-on-year. One look in any
business or consulting publication gives the same view; outsourcing
is going to explode in popularity over the next 24-36 months.
How can technology and biotech organisations focussed on
international markets and global growth capitalise on this increase
to maximise the benefit to themselves and their shareholders? The
answer lies with 'knowledge'. Technology and biotech firms, which
make up the majority of readers of this magazine, need to
understand who best can provide you with the service that will
maximise your ROI.
The best people to speak to initially are not the supplier
community themselves. They are keen to tell you that they can
provide you with an end-to-end solution, but they are being
over-optimistic. You would do much better talking to the people who
run either the VC organisations that focus on BPO and your market,
like Hibernia Partners and General Atlantic Partners, or to the
companies that provide consultancy services into this market, like
Gartner, TPI and Morgan Chambers.
Corporations need to bring outsourcing to the fore. With increased
competition and in difficult markets for UK exporters,
concentrating on core activity becomes ever more vital. Outsourcing
deals offer corporations the virtuous cycle of decreasing costs,
increasing EBITDA and the subsequent increase in shareholder
value.
Guy Kirkwood, who runs a headhunting firm focussed exclusively on
the outsourcing market, suggests the next step should be to:
"Schedule a meeting with an outsourcing consultancy or VC firm to
assess your objectives, scope, costs and the benefits of
outsourcing. A preliminary assessment will provide you with useful
information, raise questions, stimulate dialogue, and move the
process forward."
"As readers of this magazine, and therefore leaders in world-wide
growth of British companies, you should realise that now is the
time to make that strategic decision, before your international
competitors force you into such a decision."